{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:33:49Z","timestamp":1793655229083,"version":"4.5.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Virginia Tech  College of Agriculture and Life Science","award":["George Washington Carver Fellowship"],"award-info":[{"award-number":["George Washington Carver Fellowship"]}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["Gilliam Fellowship for Advanced Study"],"award-info":[{"award-number":["Gilliam Fellowship for Advanced Study"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI153433"],"award-info":[{"award-number":["R01AI153433"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["1020026"],"award-info":[{"award-number":["1020026"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zika virus (ZIKV) is an important re-emerging flavivirus that presents a significant threat to human health worldwide. Despite its importance, no vaccines are approved for use in humans. Insect-specific flaviviruses (ISFVs) have recently garnered attention as an antigen presentation platform for vaccine development and diagnostic applications. Here, we further explore the safety, immunogenicity, and efficacy of a chimeric ISFV-Zika vaccine candidate, designated Aripo-Zika (ARPV\/ZIKV). Our results show a near-linear relationship between increased dose and immunogenicity, with 10<jats:sup>11<\/jats:sup> genome copies (i.e., 10<jats:sup>8<\/jats:sup> focus forming units) being the minimum dose required for protection from ZIKV-induced morbidity and mortality in mice. Including boosters did not significantly increase the short-term efficacy of ARPV\/ZIKV-vaccinated mice. We also show that weanling mice derived from ARPV\/ZIKV-vaccinated dams were completely protected from ZIKV-induced morbidity and mortality upon challenge, suggesting efficient transfer of maternally-derived protective antibodies. Finally, in vitro coinfection studies of ZIKV with Aripo virus (ARPV) and ARPV\/ZIKV in African green monkey kidney cells (i.e., Vero-76) showed that ARPV and ARPV\/ZIKV remain incapable of replication in vertebrate cells, despite the presence of active ZIKV replication. Altogether, our data continue to support ISFV-based vaccines, and specifically the ARPV backbone is a safe, immunogenic and effective vaccine strategy for flaviviruses.<\/jats:p>","DOI":"10.1038\/s41598-023-47086-9","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:02:42Z","timestamp":1700046162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate"],"prefix":"10.1038","volume":"13","author":[{"given":"Manette","family":"Tanelus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisangel","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Porier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn I.","family":"Auguste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally L.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Auguste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"47086_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","volume":"5","author":"M-D Fernandez-Garcia","year":"2009","unstructured":"Fernandez-Garcia, M.-D., Mazzon, M., Jacobs, M. & Amara, A. Pathogenesis of flavivirus infections: Using and abusing the host cell. Cell Host Microbe 5, 318\u2013328 (2009).","journal-title":"Cell Host Microbe"},{"key":"47086_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117849","volume":"10","author":"G Moureau","year":"2015","unstructured":"Moureau, G. et al. New insights into flavivirus evolution, taxonomy and biogeographic history, extended by analysis of canonical and alternative coding sequences. PLoS ONE 10, e0117849 (2015).","journal-title":"PLoS ONE"},{"key":"47086_CR3","doi-asserted-by":"crossref","unstructured":"Dick, G. W. Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46(5), 521\u201334 (1952).","DOI":"10.1016\/0035-9203(52)90043-6"},{"key":"47086_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009055","volume":"15","author":"CJ Puntasecca","year":"2021","unstructured":"Puntasecca, C. J., King, C. H. & LaBeaud, A. D. Measuring the global burden of chikungunya and Zika viruses: A systematic review. PLoS Negl. Trop. Dis. 15, e0009055 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"47086_CR5","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy, M. R. et al. Zika virus outbreak on Yap Island, federated states of Micronesia. N. Engl. J. Med. 360, 2536\u20132543 (2009).","journal-title":"N. Engl. J. Med."},{"key":"47086_CR6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3201\/eid2410.172079","volume":"24","author":"L Subissi","year":"2018","unstructured":"Subissi, L. et al. Zika virus infection during pregnancy and effects on early childhood development, French Polynesia, 2013\u20132016. Emerg. Infect. Dis. 24, 1850 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"47086_CR7","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1016\/S1473-3099(17)30446-2","volume":"18","author":"D Musso","year":"2018","unstructured":"Musso, D. et al. Zika virus in French Polynesia 2013\u201314: Anatomy of a completed outbreak. Lancet Infect. Dis 18, e172\u2013e182 (2018).","journal-title":"Lancet Infect. Dis"},{"key":"47086_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","volume":"130","author":"SC Weaver","year":"2016","unstructured":"Weaver, S. C. et al. Zika virus: History, emergence, biology, and prospects for control. Antiviral Res. 130, 69\u201380 (2016).","journal-title":"Antiviral Res."},{"key":"47086_CR9","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika virus: New clinical syndromes and its emergence in the western hemisphere. J. Virol. 90, 4864\u20134875 (2016).","journal-title":"J. Virol."},{"key":"47086_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0140-6736(16)30902-3","volume":"388","author":"GV Fran\u00e7a","year":"2016","unstructured":"Fran\u00e7a, G. V. et al. Congenital Zika virus syndrome in Brazil: A case series of the first 1501 livebirths with complete investigation. The Lancet 388, 891\u2013897 (2016).","journal-title":"The Lancet"},{"key":"47086_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","volume":"391","author":"MR Gaudinski","year":"2018","unstructured":"Gaudinski, M. R. et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: Randomised, open-label, phase 1 clinical trials. The Lancet 391, 552\u2013562 (2018).","journal-title":"The Lancet"},{"key":"47086_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1473-3099(20)30085-2","volume":"20","author":"KE Stephenson","year":"2020","unstructured":"Stephenson, K. E. et al. Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: A single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 20, 1061\u20131070 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"47086_CR13","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.3390\/v7092851","volume":"7","author":"BG Bolling","year":"2015","unstructured":"Bolling, B. G., Weaver, S. C., Tesh, R. B. & Vasilakis, N. Insect-specific virus discovery: Significance for the arbovirus community. Viruses 7, 4911\u20134928. https:\/\/doi.org\/10.3390\/v7092851 (2015).","journal-title":"Viruses"},{"key":"47086_CR14","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3390\/v7041927","volume":"7","author":"BJ Blitvich","year":"2015","unstructured":"Blitvich, B. J. & Firth, A. E. Insect-specific flaviviruses: A systematic review of their discovery, host range, mode of transmission, superinfection exclusion potential and genomic organization. Viruses 7, 1927\u20131959 (2015).","journal-title":"Viruses"},{"key":"47086_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.meegid.2015.07.032","volume":"40","author":"M Calzolari","year":"2016","unstructured":"Calzolari, M. et al. Insect-specific flaviviruses, a worldwide widespread group of viruses only detected in insects. Infect. Genet. Evol. 40, 381\u2013388 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"47086_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/vaccines9030263","volume":"9","author":"VL Carvalho","year":"2021","unstructured":"Carvalho, V. L. & Long, M. T. Perspectives on new vaccines against arboviruses using insect-specific viruses as platforms. Vaccines 9, 263 (2021).","journal-title":"Vaccines"},{"key":"47086_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2110491119","volume":"119","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Replication is the key barrier during the dual-host adaptation of mosquito-borne flaviviruses. Proc. Natl. Acad. Sci. 119, e2110491119. https:\/\/doi.org\/10.1073\/pnas.2110491119 (2022).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"47086_CR18","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/vaccines9111230","volume":"9","author":"JJ Harrison","year":"2021","unstructured":"Harrison, J. J., Hobson-Peters, J., Bielefeldt-Ohmann, H. & Hall, R. A. Chimeric vaccines based on novel insect-specific flavi viruses. Vaccines 9, 1230 (2021).","journal-title":"Vaccines"},{"key":"47086_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030496","author":"JE Hazlewood","year":"2020","unstructured":"Hazlewood, J. E. et al. A zika vaccine generated using the chimeric insect-specific binjari virus platform protects against fetal brain infection in pregnant mice. Vaccines https:\/\/doi.org\/10.3390\/vaccines8030496 (2020).","journal-title":"Vaccines"},{"key":"47086_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.virol.2021.07.004","volume":"562","author":"AJ Auguste","year":"2021","unstructured":"Auguste, A. J. et al. Isolation of a novel insect-specific flavivirus with immunomodulatory effects in vertebrate systems. Virology 562, 50\u201362 (2021).","journal-title":"Virology"},{"key":"47086_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/vaccines9101142","volume":"9","author":"DL Porier","year":"2021","unstructured":"Porier, D. L. et al. Enemy of my enemy: A novel insect-specific flavivirus offers a promising platform for a Zika virus vaccine. Vaccines 9, 1142 (2021).","journal-title":"Vaccines"},{"key":"47086_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.626368","volume":"11","author":"Y Fang","year":"2021","unstructured":"Fang, Y. et al. Detection of DENV-2 and insect-specific flaviviruses in mosquitoes collected from Jeddah, Saudi Arabia. Front. Cell. Infect. Microbiol. 11, 626368 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"47086_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-2976-1","volume":"18","author":"MY Carrillo-Hern\u00e1ndez","year":"2018","unstructured":"Carrillo-Hern\u00e1ndez, M. Y., Ruiz-Saenz, J., Villamizar, L. J., G\u00f3mez-Rangel, S. Y. & Mart\u00ednez-Gutierrez, M. Co-circulation and simultaneous co-infection of dengue, chikungunya, and Zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border. BMC Infect. Dis. 18, 1\u201312 (2018).","journal-title":"BMC Infect. Dis."},{"key":"47086_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13071-017-2087-7","volume":"10","author":"K Erg\u00fcnay","year":"2017","unstructured":"Erg\u00fcnay, K. et al. Co-circulation of West Nile virus and distinct insect-specific flaviviruses in Turkey. Parasites Vectors 10, 149. https:\/\/doi.org\/10.1186\/s13071-017-2087-7 (2017).","journal-title":"Parasites Vectors"},{"key":"47086_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.chom.2019.10.001","volume":"26","author":"RA Larocca","year":"2019","unstructured":"Larocca, R. A. et al. Adenovirus vector-based vaccines confer maternal-fetal protection against Zika virus challenge in pregnant IFN-\u03b1\u03b2R\u2212\/\u2212 mice. Cell Host Microbe 26, 591\u2013600 (2019).","journal-title":"Cell Host Microbe"},{"key":"47086_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00383-00321","author":"X Ye","year":"2021","unstructured":"Ye, X. et al. A live-attenuated zika virus vaccine with high production capacity confers effective protection in neonatal mice. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00383-00321 (2021).","journal-title":"J. Virol."},{"key":"47086_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13288","volume":"84","author":"ARY Collier","year":"2020","unstructured":"Collier, A. R. Y. et al. Sustained maternal antibody and cellular immune responses in pregnant women infected with Zika virus and mother to infant transfer of Zika-specific antibodies. Am. J. Reprod. Immunol. 84, e13288 (2020).","journal-title":"Am. J. Reprod. Immunol."},{"key":"47086_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007648","volume":"13","author":"T Singh","year":"2019","unstructured":"Singh, T. et al. Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy. PLoS Neglect. Trop. Dis. 13, e0007648 (2019).","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"47086_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"47086_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763\u2013767 (2017).","journal-title":"Nat. Med."},{"key":"47086_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.08.056","volume":"36","author":"J Zou","year":"2018","unstructured":"Zou, J. et al. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity. EBioMedicine 36, 92\u2013102 (2018).","journal-title":"EBioMedicine"},{"key":"47086_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","volume":"170","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273\u2013283 (2017).","journal-title":"Cell"},{"key":"47086_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00701-00718","author":"P Li","year":"2018","unstructured":"Li, P. et al. Zika virus attenuation by codon pair deoptimization induces sterilizing immunity in mouse models. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00701-00718 (2018).","journal-title":"J. Virol."},{"key":"47086_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/vaccines8020258","volume":"8","author":"LJ Vet","year":"2020","unstructured":"Vet, L. J. et al. Protective efficacy of a chimeric insect-specific flavivirus vaccine against West Nile virus. Vaccines 8, 258 (2020).","journal-title":"Vaccines"},{"key":"47086_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030368","author":"K Yan","year":"2020","unstructured":"Yan, K. et al. A yellow fever virus 17D infection and disease mouse model used to evaluate a chimeric Binjari-yellow fever virus vaccine. Vaccines https:\/\/doi.org\/10.3390\/vaccines8030368 (2020).","journal-title":"Vaccines"},{"key":"47086_CR36","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/S1473-3099(20)30733-7","volume":"21","author":"H-H Han","year":"2021","unstructured":"Han, H.-H., Diaz, C., Acosta, C. J., Liu, M. & Borkowski, A. Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial. Lancet Infect. Dis. 21, 1282\u20131292 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"47086_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/vaccines8020266","volume":"8","author":"A Pattnaik","year":"2020","unstructured":"Pattnaik, A., Sahoo, B. R. & Pattnaik, A. K. Current status of Zika virus vaccines: successes and challenges. Vaccines 8, 266 (2020).","journal-title":"Vaccines"},{"key":"47086_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","volume":"391","author":"K Modjarrad","year":"2018","unstructured":"Modjarrad, K. et al. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical trials. The Lancet 391, 563\u2013571 (2018).","journal-title":"The Lancet"},{"key":"47086_CR39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708120","volume":"385","author":"P Tebas","year":"2021","unstructured":"Tebas, P. et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine. N. Engl. J. Med. 385, e35 (2021).","journal-title":"N. Engl. J. Med."},{"key":"47086_CR40","volume-title":"Vaccines-the History and Future","author":"X Dai","year":"2019","unstructured":"Dai, X., Xiong, Y., Li, N. & Jian, C. Vaccines-the History and Future (IntechOpen, 2019)."},{"key":"47086_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3748\/wjg.v7.i1.98","volume":"7","author":"H Ren","year":"2001","unstructured":"Ren, H., Zhu, F. L., Zhu, S. Y., Song, Y. B. & Qi, Z. T. Immunogenicity of HGV NS5 protein expressed from Sf9 insect cells. World J. Gastroenterol. 7, 98 (2001).","journal-title":"World J. Gastroenterol."},{"key":"47086_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","volume":"31","author":"GM Glenn","year":"2013","unstructured":"Glenn, G. M. et al. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine 31, 524\u2013532 (2013).","journal-title":"Vaccine"},{"key":"47086_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.12665\/J122.Hahn","volume":"12","author":"TJ Hahn","year":"2013","unstructured":"Hahn, T. J. et al. Rapid manufacture and release of a GMP batch of avian influenza A (H7N9) virus-like particle vaccine made using recombinant baculovirus-Sf9 insect cell culture technology. BioProcess. J. 12, 4\u201317 (2013).","journal-title":"BioProcess. J."},{"key":"47086_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.12665\/J141.Hahn","volume":"14","author":"TJ Hahn","year":"2015","unstructured":"Hahn, T. J. et al. Rapid manufacture and release of a GMP batch of zaire ebolavirus glycoprotein vaccine made using recombinant baculovirus-Sf9 insect cell culture technology. Bioprocess. J. 14, 6\u201318 (2015).","journal-title":"Bioprocess. J."},{"key":"47086_CR45","doi-asserted-by":"crossref","unstructured":"Shan, C., Xie, X. & Shi, P.-Y. Reverse genetics of Zika virus. Methods Mol Biol. 1602, 47\u201358 (2017).","DOI":"10.1007\/978-1-4939-6964-7_4"},{"key":"47086_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","volume":"65","author":"AP Durbin","year":"2001","unstructured":"Durbin, A. P. et al. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2019-untranslated region. Am. J. Trop. Med. Hyg. 65, 405\u2013413 (2001).","journal-title":"Am. J. Trop. Med. Hyg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47086-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:09:44Z","timestamp":1700046584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47086"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47086-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19948"}}